Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2014 09:15 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at the 2014 Wedbush Life Sciences Conference

BRISBANE, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Wedbush 2014 Life Sciences Conference on...
August 04, 2014 09:15 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Report Second Quarter 2014 Financial Results After Market on August, 7, 2014

BRISBANE, Calif., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report second quarter 2014 financial results after market close on Thursday,...
June 25, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics Announces EMA Acceptance for Review of Marketing Authorization Application for RAVICTI(R)

BRISBANE, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the European Medicines Agency (EMA) has completed technical and content validation...
June 18, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at the JMP Healthcare Conference

BRISBANE, Calif., June 18, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the JMP Healthcare Conference on Tuesday, June 24,...
June 12, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at 2014 Wells Fargo Healthcare Conference

BRISBANE, Calif., June 12, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the 2014 Wells Fargo Healthcare Conference on...
June 12, 2014 08:46 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics Completes Acquisition of Andromeda Biotech, Ltd.

- Hyperion's Orphan Drug Pipeline Now Includes DiaPep277®, a First-in-Class Immunotherapy for New Onset Type 1 Diabetes, With Phase 3 Data Expected in the First Quarter of 2015...
June 03, 2014 08:00 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics Announces Health Canada Accepts RAVICTI(R) New Drug Submission With Priority Review

BRISBANE, Calif., June 3, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the validation period is complete for its New Drug Submission (NDS) to Health Canada...
May 28, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at Jefferies 2014 Global Healthcare Conference

BRISBANE, Calif., May 28, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the Jefferies Global Healthcare Conference on...
May 07, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at Bank of America Merrill Lynch 2014 Health Care Conference

BRISBANE, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) today announced that the company is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care...
May 06, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics Announces First Quarter 2014 Financial Results

- Company signs definitive agreement to expand its pipeline - - Company to Host Conference Call Today at 4:30 p.m. ET (1:30 p.m. PT) - BRISBANE, Calif., May 6, 2014 (GLOBE NEWSWIRE) --...